Private Market View

Watershed Therapeutics

Bellevue, WA · Founded 2019 · Privately Held (backing)

PA Mark · $/share
$384
Sep 2026
Implied valuation
$24.9M
Total raised
$9.0M
Last round
What is Watershed Therapeutics worth?
$24.9Mlast known valuation
Free account
See the evidence behind this price
  • ·The complete investor list — 10 names
  • ·Watchlist + deal alerts for Watershed Therapeutics
  • ·The full record, as it builds
Create free account
No card required

Funding history

No rounds on record

No funding rounds for Watershed Therapeutics are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.

Pro members can request priority coverage with a 48-hour turnaround.

How Watershed Therapeutics's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Watershed Therapeutics, we compose those signals into the PA Mark — a weighted composite of 2 recent pricing inputs, decayed by age and reset on new rounds. The implied valuation multiplies the mark by shares outstanding. Full methodology →

Frequently asked

What is Watershed Therapeutics worth?
Watershed Therapeutics's implied valuation is $24.9M, based on the PA Mark composite price of about $384 per share as of Sep 2026.
How much has Watershed Therapeutics raised?
Watershed Therapeutics has raised $9.0M in total funding across its recorded rounds.
Watershed Therapeutics Valuation 2026 — $24.9M | Private Market View